Pricing Log in Create free account
Friday 6 November 2026 Export CL’s income statement to Excel — free account

Colgate-Palmolive Company

CL Consumer Defensive Household & Personal Products

Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.

Revenue
+4.64%
EPS
+7.42%
Free cash flow
−6.24%
Total debt
−8.35%

Quarter to September 2026, against a year earlier

98.63 0.13 −0.13%
Market cap
$78.5B
P/E
37.8×
Fwd P/E
26.3×
Dividend yield
2.14%
F-score
6/9
Altman Z
6.51
Beneish M
−3.04
Dividend safety
66/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Revenue by segment Fiscal 2025

  • Oral, Personal and Home Care
  • Hill's Pet Nutrition

Every year since 2011 →

Insider Decisions last twelve months

Sold, $m 57.01
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — 7 — — 2 — — 3 — — —
Insider Ownership 0.44%

Capital & Financial Ratios $m

Size
Market Cap 78,450.00
Revenue ttm 21,284.00
Net income ttm 2,176.00
Free cash flow ttm 3,789.00
Net debt Q 6,189.00
Valuation
P/E 37.83 (above 35: high)
Forward P/E 26.30
Price / sales 3.69
Forward P/S Powerpack
Price / FCF 20.74
Price / book 122.81 (above 6: high)
Financial health
Current ratio Q 0.96 (below 1: weak)
Debt / equity Q 12.06 (above 2: weak)
Interest coverage Q 17.55
Growth
Revenue growth Q +4.64% (above 0%: growing)
Operating income growth Q +2.74% (above 0%: growing)
EPS, this year +6.12%
EPS, next year A +4.75%
Revenue, next year A +4.99%
EPS, past 5 yrs −3.48% (below 0%: weak)
EPS, next 5 yrs A +6.12%

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 4.0×, against a ten-year median of 4.1×; over the ten years it ranged from 3.5× in 2025 to 4.9× in 2020.
P/E against its own 10 years 84.34%
10-year low 10-year high
P/S against its own 10 years 38.14%
10-year low 10-year high
P/B against its own 10 years 49.06%
10-year low 10-year high
EV/Sales against its own 10 years 28.90%
10-year low 10-year high
EV/FCF against its own 10 years 16.28%
10-year low 10-year high

Dividends raised every year since 2018

Yield
2.14%
Annual rate
2.11
Payout ratio
81.7%
Growth, 2018–26
+3.04%/yr
  1. 1.66 ’18
  2. 1.71 ’19 +3
  3. 1.75 ’20 +2
  4. 1.79 ’21 +2
  5. 1.86 ’22 +4
  6. 1.91 ’23 +3
  7. 1.98 ’24 +4
  8. 2.06 ’25 +4
  9. 2.11 ’26 +2
paid change on the year, % Powerpack

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 966 1,096 1,288 1,527
Receivables 1,586 1,521 1,675 1,901
Inventory 1,934 1,987 2,032 2,182
Other 793 713 714 747
5,279 5,317 5,709 6,357
2023 2024 2025 Q'26
Payables 1,698 1,805 2,089 2,096
ST’ Debt 330 660 1,117 532
Other — — — —
4,741 5,759 6,853 6,639

Compound Annual Growth %

10y 5y 3y
Sales 2.43% 4.35% 4.29%
Cash Flow 3.59% 2.45% 17.99%
Earnings 4.42% (4.58%) 6.10%
Book Value 0.00% (19.81%) (23.21%)

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.92 Actual 0.97

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.91 0.95 Beat by 0.04
Q1 FY26 0.95 0.97 Beat by 0.02
Q2 FY26 0.95 0.99 Beat by 0.04
Q3 FY26 0.92 0.97 Beat by 0.05
Q4 FY26 0.97 — Reports 29 January 2027

EPS $

Mar Jun Sep Dec Year
’26 0.80 0.86 0.97 — —
’25 0.85 0.91 0.91 (0.05) 2.63
’24 0.83 0.89 0.90 0.90 3.51
’23 0.45 0.60 0.86 0.87 2.77
’22 0.66 0.72 0.74 0.01 2.13
’21 0.80 0.83 0.75 0.18 2.55
’20 0.83 0.74 0.81 0.75 3.14
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 5,324 5,361 5,369 — —
’25 4,911 5,110 5,131 5,230 20,382
’24 5,065 5,058 5,033 4,945 20,101
’23 4,770 4,822 4,915 4,950 19,457
’22 4,399 4,484 4,455 4,629 17,967
’21 4,344 4,260 4,414 4,403 17,421
’20 4,097 3,897 4,153 4,324 16,471
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 747 995 1,171 — —
’25 600 884 1,261 1,453 4,198
’24 681 990 1,167 1,269 4,107
’23 735 722 1,152 1,136 3,745
’22 386 528 969 673 2,556
’21 598 627 994 1,106 3,325
’20 768 1,026 962 963 3,719
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 609 867 1,037 — —
’25 476 776 1,106 1,276 3,634
’24 555 873 1,033 1,085 3,546
’23 572 538 991 939 3,040
’22 264 350 841 452 1,907
’21 491 497 857 913 2,758
’20 686 949 872 802 3,309
Fiscal quarters ending in the months shown.

Valuation

The price implies free cash flow after share-based pay growing 7.8% a year for ten years. It grew 4.5% a year over the last ten.

Implied
7.8%
10 years, reported
4.5%
Open the model

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 15,195 15,454 15,544 15,693 16,471 17,421 17,967 19,457 20,101 20,382 21,284 +3.3% 21,399 22,063 22,844 +3.9%
Gross margin, % 60.04 60.05 59.39 59.42 60.82 59.55 57.04 58.21 60.50 60.11 60.61 +0.1 pt
EBT 3,738 3,487 3,464 3,301 3,647 3,087 2,660 3,392 3,956 3,059 2,968 (2.2%)
EBT margin, % 24.60 22.56 22.29 21.03 22.14 17.72 14.80 17.43 19.68 15.01 13.94 (9.6) pt
Net income 2,586 2,174 2,558 2,527 2,860 2,338 1,967 2,455 3,049 2,261 2,176 (1.5%)
Per share, $
Per share, $ Revenue 17.04 17.53 17.85 18.27 19.22 20.62 21.48 23.52 24.54 25.20 26.71 +4.4%
Earnings 2.74 2.30 2.76 2.76 3.15 2.56 2.13 2.78 3.53 2.64 2.61 (0.4%)
Cash flow 3.52 3.46 3.51 3.65 4.34 3.93 3.06 4.53 5.01 5.19 5.48 +4.4%
Capex (0.60) (0.58) (0.50) (0.39) (0.48) (0.67) (0.78) (0.85) (0.68) (0.70) (0.72) +1.7%
Free cash flow 2.92 2.89 3.01 3.26 3.86 3.26 2.28 3.67 4.33 4.49 4.75 +4.9%
Book value 0.02 0.28 0.23 0.65 1.29 1.15 0.96 1.16 0.66 0.45 0.80 +42.1%
Shares, m 892 882 871 859 857 845 836 827 819 809 802 (1.1%)
Valuation, ×
Valuation, × P/E 23.92 32.81 21.64 25.03 27.23 33.34 36.98 28.93 25.75 30.05 37.83 28.6
P/S 3.85 4.29 3.33 3.77 4.45 4.14 3.68 3.43 3.70 3.14 3.69 3.8
P/B 3,438.15 272.67 263.04 105.99 66.54 74.27 82.11 69.79 136.88 175.08 122.81 468.5
EV/Sales 4.25 4.67 3.75 4.20 4.84 4.51 4.13 3.82 4.05 3.46 3.98 4.2
EV/FCF 24.75 28.37 22.27 23.53 24.09 28.46 38.89 24.46 22.93 19.43 22.38 25.7
Cash, $m
Cash, $m Operating cash flow 3,141 3,054 3,056 3,133 3,719 3,325 2,556 3,745 4,107 4,198 4,366 +3.3%
Capex (533) (509) (436) (335) (410) (567) (649) (705) (561) (564) (577) +0.6%
Free cash flow 2,608 2,545 2,620 2,798 3,309 2,758 1,907 3,040 3,546 3,634 3,789 +3.8%
Balance, $m
Balance, $m Working capital 1,033 1,231 452 141 (66) 346 1,109 538 (442) (1,144) (282) n/m
Net debt 5,218 5,042 5,640 6,704 6,455 6,374 7,980 7,583 6,853 6,700 6,189 +2.8%
Shareholders’ equity 17 243 197 558 1,101 971 806 957 544 365 640 +40.6%
Returns, %
Returns, % ROA 20.29 16.32 19.33 17.41 17.41 13.99 11.60 14.32 17.81 13.17 11.99 (7.1) pt
ROIC 47.22 43.84 39.55 30.59 32.14 28.35 20.58 29.16 36.06 29.25 28.91 (18.0) pt
ROE (18,081.48) 1,556.92 1,090.91 627.02 324.89 209.07 200.90 260.92 384.94 469.09 218.74 +18,550.6 pt
People
People Employees 36,700 35,900 34,500 34,300 34,200 33,800 33,800 34,000 34,000 33,600 — (1.0%)
Revenue/emp, $m 0.41 0.43 0.45 0.46 0.48 0.52 0.53 0.57 0.59 0.61 — +4.3%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 3 Nov 2026

Business profile

Updated

Colgate-Palmolive sells oral care, personal care, home care and pet nutrition products. It is headquartered in New York City and led by Chairman, President and CEO Noel Wallace.

Its oral care products include Colgate toothpaste, toothbrushes and mouthwash, as well as products for dentists and other oral health professionals. Personal care brands include Palmolive and Softsoap hand soap, Irish Spring body wash, Speed Stick deodorant and EltaMD skin care. Home care products include Palmolive dishwashing liquid, Fabuloso household cleaners and Suavitel fabric conditioner.

Where the money comes from and where it goes Fiscal 2025

Fiscal 2025: revenue by segment, and margins
Oral, Personal and Home Care 15,769 77.37%
Hill's Pet Nutrition 4,613 22.63%
Gross margin 60.11%
Operating margin 16.22%
Pre-tax margin 15.01%

Revenue by segment since 2011

Colgate-Palmolive Company vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
PG Procter & Gamble Company (The) $387.3B 24.7× 23.6× +3.98% (above 0%: growing) 0.00% +5.03% (above 0%: growing) 49.83% 25.51% Compare
UL Unilever PLC $145.9B 11.4× — +8.58% (above 0%: growing) +8.84% (above 0%: growing) −19.66% (below 0%: shrinking) 0.00% 0.00% Compare
CL Colgate-Palmolive Company $78.5B 37.8× 26.3× +4.64% (above 0%: growing) +7.42% (above 0%: growing) −6.24% (below 0%: shrinking) 60.22% 20.26%
KMB Kimberly-Clark Corporation $67.8B 18.8× 16.9× +0.62% (above 0%: growing) −32.03% (below 0%: shrinking) −4.79% (below 0%: shrinking) 38.27% 15.11% Compare
EL The Estee Lauder Companies Inc. $39.0B 106× 37.4× +6.72% (above 0%: growing) +393.31% (above 0%: growing) +46.10% (above 0%: growing) 75.72% 10.98% Compare
CHD Church & Dwight Co., Inc. $26.3B 34.1× 28.9× +1.04% (above 0%: growing) +19.33% (above 0%: growing) −16.57% (below 0%: shrinking) 46.78% 18.19% Compare
CLX The Clorox Company $12.1B 17.8× 15.6× +33.31% (above 0%: growing) +118.85% (above 0%: growing) +84.21% (above 0%: growing) 40.42% 13.70% Compare
ELF e.l.f. Beauty $6.5B 76.1× 59.3× +51.43% (above 0%: growing) +920.00% (above 0%: growing) −26.99% (below 0%: shrinking) 71.09% 10.07% Compare
IPAR Interparfums, Inc. $4.3B 25.5× 23.8× −0.02% (below 0%: shrinking) +3.90% (above 0%: growing) −6.15% (below 0%: shrinking) 67.10% 27.44% Compare
Median of peers $32.6B 25.1× 23.8× +5.35% +14.09% −5.47% 48.31% 14.41%

All 30 Household & Personal Products stocks →

From the latest earnings call

Updated

  • CEO Noel Wallace said organic sales grew across all four categories and described a U.S. turnaround focused on premium innovation and support for core brands.
  • CFO Stan Sutula said productivity and pricing helped offset material inflation, while commodity and logistics costs were expected to remain elevated into next year.

Analyst rating changes each firm’s latest, last six months

Firm Date Action Rating Target
Bernstein Oct 9, 2026 Initiated Hold —

Largest institutional holders 13F, quarter to 30 June 2026

Held by institutions 84.88%
Held by the ten largest 41.05%
Holder Shares Stake Change
Vanguard 84.88m 10.65% +375.23k
BlackRock 69.92m 8.77% −2.73m
State Street 47.02m 5.90% −698.52k
T. Rowe Price 27.94m 3.50% −5.82m
Geode Capital Management 23.14m 2.90% +244.03k
Morgan Stanley 22.07m 2.77% +1.19m
First Eagle Investment Management, LLC 16.41m 2.06% +8.29m
BNY 13.53m 1.70% +1.01m
Deutsche Bank (DWS) 11.75m 1.47% −176.19k
UBS 10.56m 1.33% −880.54k
13F filings for the quarter to 30 June 2026: long positions in US-listed shares reported by managers with $100m or more, ~45 days after the quarter.

Pay and ownership Proxy statement filed 25 March 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 16.48m 12.34m 104.00
2024 18.23m 31.68m 116.80
2023 17.12m 19.46m 100.20
2022 14.46m 11.05m 96.50
2021 15.46m 18.01m 102.10
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Read the proxy statement

Colgate-Palmolive Company (CL) Latest News

2 Nov

Impact 3 · · StockStory

30 Oct

Impact 3 · · Moby
Impact 3 · · MarketBeat transcript
Impact 3 · · The Motley Fool transcript
Impact 3 · · Zacks
Impact 3 · · MT Newswires
Impact 3 · · Investing.com
Impact 3 · · Business Wire

29 Oct

Impact 3 · · StockStory

28 Oct

Impact 3 · · Simply Wall St.
Impact 3 · · MT Newswires
Impact 3 · · Trefis

26 Oct

Impact 3 · · Trefis
Impact 3 · · Zacks earnings
Impact 3 · · Zacks
Impact 3 · · 24/7 Wall St.

24 Oct

Impact 4 · · Simply Wall St.
Impact 3 · · Simply Wall St.

23 Oct

Impact 3 · · Zacks

22 Oct

Impact 3 · · Zacks

15 Oct

Impact 3 · · Barchart

14 Oct

Impact 4 · · Simply Wall St.
Impact 3 · · Simply Wall St.

11 Oct

Impact 3 · · Insider Monkey

9 Oct

Impact 3 · · Insider Monkey

7 Oct

Impact 3 · · Simply Wall St.

6 Oct

Impact 3 · · StockStory

30 Sep

Impact 4 · · Zacks
Impact 3 · · 24/7 Wall St.

28 Sep

Impact 4 · · Insider Monkey

CL metrics, ten years each

stockrow.com/CL · Data as of Nov 3, 2026 · For information only; not investment advice. · © 2026 stockrow.com